TCT-160 Effects of PRT-201, a Recombinant Human Type I Pancreatic Elastase, Treatment on the Elastin Content and Compliance of Atherosclerotic Tibial Arteries Using a Perfusion Myograph  by Burke, Steven et al.
Conclusions: Greater concentrations of CD40L and TNF-B were seen at the site of
stenosis and may promote inflammation in symptomatic SFA disease. A local inflamma-
tory response is particularly notable in newly diagnosed, symptomatic patients not
currently taking aspirin, clopidogrel or a statin.
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Background: The presence of clinical peripheral arterial disease (PAD) is associated
with an increased risk of adverse cardiovascular outcomes among patients with coronary
artery disease (CAD). However, there is little data regarding the impact of the presence
and degree of the subclinical PAD on outcomes in patients with CAD, specially those that
undergoing percutaneous coronary intervention (PCI) for ST-elevation-myocardial infarc-
tion (STEMI). We aimed to assess prospectively the grade of subclinical PAD in the
setting of patients that undergoing primary PCI for prediction of middle and long-term
clinical outcomes.
Methods: A total of 971 consecutive patients without history of clinical PDA that
undergoing primary PCI for STEMI were included in a prospective follow-up. Subclinical
PAD severity was blindly assessed based on a previously described ultrasound arterial
morphology classification (UAMC) defined with an high-resolution ultrasound assess-
ment of wall carotid and femoral artery bifurcations. This classification included four
classes (I: normal, II: wall thickening, III: non-stenosing plaques, IV: stenosing plaques)
corresponding to four scores ranging between 2 and 8 for each artery (total score from 8
to 32 in each patient. The group was divided into four classes according to UAMC and
each patient was assigned a score. We evaluated death, and major cardiovascular and
cerebrovascular events after 40 months’mean follow-up.
Results: At multivariable analysis, mortality in class IV group was more than 16-fold
higher (hazard ratio [HR], 16.50; 95% confidence interval [CI], 7.76 to 35.07; P0.001)
when compared with the class I group and was also increased in the class III group (HR,
4.47; 95% CI, 2.55 to 8.76; P0.001) and class II group (HR, 1.62; 95% CI, 1.30 to 2.18;
P 0.05). Similarly, an increasing effect was seen across UAMC strata for MACCE in the
class IV group (HR, 12.29; 95% CI, 9.16 to 16.50; P0.001), class III group (HR, 11.70;
95% CI, 8.54 to 16.24; P 0.001), and class II group (HR, 1.92; 95% CI, 1.40 to 2.55;
P0.005).
Conclusions: The UAMC may be applied in the STEMI population that undergoing
primary PCI and is able to stratify patients for poor middle and long term clinical
outcomes.
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Background: At physiologic pressures, the elastin fiber network constrains artery
diameter. Fragmenting elastin fibers following successful angioplasty of atherosclerotic
arteries could result in larger artery lumen diameter and area. The purpose of this study
was to investigate the use of PRT-201, a recombinant human type I pancreatic elastase,
as an adjuvant therapy to balloon angioplasty for treatment of peripheral artery disease
(PAD).
Methods: Diseased tibial arteries were harvested from patients undergoing lower limb
amputations for PAD. Ex vivo balloon angioplasty was performed using a balloon chosen
to match the lumen diameter of the artery taken at the intima-plaque interface. Thereafter,
the arteries were cut into 6 x 1.5 mm rings and studied on a wire myograph to obtain
baseline compliance data. Then the external surface of the artery was bathed in PRT-201
2 mg/mL or saline for 60 minutes and myography was repeated. Treated rings were
analyzed for desmosine (elastin) content by RIA and elastin fiber staining by histology.
Desmosine is a protein cross-link unique to elastin.
Results: PRT-201 but not saline caused a shift in the compliance curve of artery rings
from the anterior and posterior tibial arteries (Figure) associated with an increases in
lumen diameter and area across a range of pressures. PRT-201 treatment reduced
desmosine (elastin) content by 60% and reduced elastin fiber staining on histology.
Conclusions: The results suggest that PRT-201 treatment following balloon angioplasty
of atherosclerotic arteries could increase artery lumen diameter and area without requiring
placement of a stent.
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Background: At physiologic pressures, elastin fibers constrain artery diameter. Remov-
ing elastin fibers from an atherosclerotic artery could result in larger artery lumen diameter
and greater blood flow. The purpose of this study was to investigate the use of PRT-201
as a treatment for peripheral artery disease (PAD).
Methods: Anterior and posterior tibial arteries were obtained within 24 hrs of death from
persons who donated their bodies to science. The arteries were visually atherosclerotic.
3-4 cm long segments of artery were mounted onto the perfusion myograph and bathed
in Krebs solution at 37C gassed with a mix of 95% O2/ 5% CO2. Transmural pressures
were increased from 10 to 80 mmHg while diameter was continuously recorded to create
a compliance curve. Then PRT-201 was applied at a concentration of 3.6 mg/mL for 30
min and the compliance curve was repeated. The artery was analyzed for elastin content
by desmosine radioimmunoassay (RIA). Desmosine is a protein cross-link unique to
elastin.
Results: 6 donors provided 10 tibial arteries. The figure displays the compliance curves
for the tibial arteries pre- and post-PRT-201. Average anterior tibial artery diameter
increased by 0.78  0.21 mm (27  12%) and average posterior tibial artery diameter
increased by 0.58  0.30 mm (21  11%), all p0.001, following PRT-201 treatment.
PRT-201 reduced elastin content measured by desmosine RIA by approximately 50%.
Conclusions: PRT-201 treatment removed elastin from atherosclerotic tibial arteries and
altered artery compliance so as to increase artery diameter.
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Background: Therapeutic vasculogenesis in patient with critical limb ischemia (CLI) is
an experimental method with good short term results. Successful vasculogenesis is
achieved by transcatheter intra-arterial administration of autologous bone marrow mono-
nuclear cells (BMMC) directly into the ischemic foot. However, the longterm effects of
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